BG62257B1 - 2-оксо и 2-тио-1,2-дихидрохинолинилоксазолидинони - Google Patents

2-оксо и 2-тио-1,2-дихидрохинолинилоксазолидинони Download PDF

Info

Publication number
BG62257B1
BG62257B1 BG101131A BG10113197A BG62257B1 BG 62257 B1 BG62257 B1 BG 62257B1 BG 101131 A BG101131 A BG 101131A BG 10113197 A BG10113197 A BG 10113197A BG 62257 B1 BG62257 B1 BG 62257B1
Authority
BG
Bulgaria
Prior art keywords
carbon atoms
linear
different
phenyl
branched
Prior art date
Application number
BG101131A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101131A (en
Inventor
Dieter Haebich
Andreas Stolle
Bernd Riedl
Martin Ruppelt
Stephan Bartel
Walter Guarnieri
Rainer Endermann
Hein-Peter Kroll
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG101131A publication Critical patent/BG101131A/xx
Publication of BG62257B1 publication Critical patent/BG62257B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BG101131A 1996-01-16 1997-01-14 2-оксо и 2-тио-1,2-дихидрохинолинилоксазолидинони BG62257B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601265A DE19601265A1 (de) 1996-01-16 1996-01-16 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone

Publications (2)

Publication Number Publication Date
BG101131A BG101131A (en) 1998-04-30
BG62257B1 true BG62257B1 (bg) 1999-06-30

Family

ID=7782816

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101131A BG62257B1 (bg) 1996-01-16 1997-01-14 2-оксо и 2-тио-1,2-дихидрохинолинилоксазолидинони

Country Status (28)

Country Link
US (1) US5861413A (xx)
EP (1) EP0785197A3 (xx)
JP (1) JPH09194478A (xx)
KR (1) KR970059174A (xx)
AR (1) AR005458A1 (xx)
AU (1) AU711924B2 (xx)
BG (1) BG62257B1 (xx)
BR (1) BR9700688A (xx)
CA (1) CA2194945A1 (xx)
CO (1) CO4520188A1 (xx)
CZ (1) CZ12897A3 (xx)
DE (1) DE19601265A1 (xx)
EE (1) EE9700019A (xx)
HN (1) HN1996000124A (xx)
HR (1) HRP960614A2 (xx)
HU (1) HUP9700126A3 (xx)
IL (1) IL119994A0 (xx)
NO (1) NO970174L (xx)
NZ (1) NZ314057A (xx)
PE (1) PE35398A1 (xx)
PL (1) PL317930A1 (xx)
SG (1) SG46764A1 (xx)
SK (1) SK5897A3 (xx)
SV (1) SV1997000002A (xx)
TN (1) TNSN97009A1 (xx)
TR (1) TR199601002A1 (xx)
YU (1) YU1097A (xx)
ZA (1) ZA97302B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
EP1049682A1 (en) 1998-01-23 2000-11-08 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
IL140084A0 (en) * 1998-06-05 2002-02-10 Astra Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6544991B2 (en) 2000-06-30 2003-04-08 Pharmacia & Upjohn Company Compositions and methods for treating bacterial infections
US6689769B2 (en) 2000-12-21 2004-02-10 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
EP1539745B1 (en) * 2002-08-12 2006-03-29 Pharmacia & Upjohn Company LLC N-aryl-2-oxazolidinones and their derivatives
WO2004026848A1 (en) * 2002-09-20 2004-04-01 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
US7141570B2 (en) * 2002-11-21 2006-11-28 Pharmacia & Upjohn Company N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
EP1567520B1 (en) * 2002-12-04 2008-10-15 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
CA2515311A1 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
BRPI0407304A (pt) * 2003-02-07 2006-01-10 Warner Lambert Co Agentes antibacterianos
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2004096221A1 (en) 2003-04-30 2004-11-11 Morphochem Aktiengesellschaft für kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
CA2549675C (en) 2003-12-18 2012-11-20 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US7494578B2 (en) * 2004-03-01 2009-02-24 Atotech Deutschland Gmbh Iron-phosphorus electroplating bath and method
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
CA2713187C (en) * 2008-02-22 2016-06-07 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
WO2016020836A1 (en) * 2014-08-06 2016-02-11 Novartis Ag Quinolone derivatives as antibacterials
KR20220055171A (ko) * 2020-10-26 2022-05-03 주식회사 아이비스바이오 포말리도마이드로부터 3,6'-디티오포말리도마이드를 선택적으로 합성하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
EP0609905B1 (en) 1988-09-15 2001-06-06 PHARMACIA & UPJOHN COMPANY 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
JP2669579B2 (ja) * 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (xx) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
DE19601265A1 (de) 1997-07-17
SV1997000002A (es) 1997-08-29
EP0785197A3 (de) 1999-02-10
ZA97302B (en) 1997-07-17
NZ314057A (en) 1998-11-25
KR970059174A (ko) 1997-08-12
NO970174D0 (no) 1997-01-15
HU9700126D0 (en) 1997-02-28
SG46764A1 (en) 1998-02-20
JPH09194478A (ja) 1997-07-29
EP0785197A2 (de) 1997-07-23
AU711924B2 (en) 1999-10-21
TNSN97009A1 (fr) 2005-03-15
PE35398A1 (es) 1998-08-29
AU1009797A (en) 1997-07-24
TR199601002A1 (tr) 1997-08-21
HUP9700126A2 (hu) 1998-12-28
SK5897A3 (en) 1997-09-10
MX9700419A (es) 1997-07-31
AR005458A1 (es) 1999-06-23
CZ12897A3 (en) 1997-08-13
US5861413A (en) 1999-01-19
BR9700688A (pt) 1998-09-01
CO4520188A1 (es) 1997-10-15
HN1996000124A (es) 1997-06-18
HRP960614A2 (en) 1998-02-28
BG101131A (en) 1998-04-30
EE9700019A (et) 1997-08-15
HUP9700126A3 (en) 1999-05-28
YU1097A (xx) 1999-12-27
PL317930A1 (en) 1997-07-21
IL119994A0 (en) 1997-04-15
NO970174L (no) 1997-07-17
CA2194945A1 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
BG62257B1 (bg) 2-оксо и 2-тио-1,2-дихидрохинолинилоксазолидинони
US5869659A (en) Heteroatom-containing cyclopentanopyridyl-oxazolidinones
HRP950408A2 (en) 6-membered n-heteroaryloxazolidinones
JPH101480A (ja) 新規なヘテロアリール−オキサゾリジノン類
US20060205719A1 (en) Novel compounds having an antibacterial activity
CZ12997A3 (en) Pyrido-annelated and thienyl- and furanyl-oxazolidinones, process of their preparation, their use and pharmaceutical composition containing thereof
SK15897A3 (en) Substituted oxazolidinones, process for producing them, their use and pharmaceutical composition containing these substances
MXPA97000885A (es) Nuevas heteroariloxazolidinonas
BG99791A (en) 5-member heteroaryloxazolidinons
AU2019383103B2 (en) Aromatic ring-linked dioxane-quinazoline or -quinoline compounds, compositions and use thereof
JP2018502841A (ja) Ｈｄａｃ１／２阻害剤としてのピペリジン誘導体
KR20090042971A (ko) 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드
KR20180048798A (ko) 트립토판 디옥시게나제 (ido1 및 tdo)의 억제제 및 치료에서 이들의 용도
NL1027545C2 (nl) Chinolonen als antibacteriele middelen.
EP2367820B1 (en) Novel antimicrobial agents
DE19649095A1 (de) Neue Heteroaryl-Oxazolidinone
JP2645091B2 (ja) ７‐（２‐メチル‐４‐アミノピロリジニル）ナフチリジン及びキノリン化合物
KR20020084274A (ko) 신규한 벤조술탐 옥사졸리디논 항균제
KR100467309B1 (ko) 옥사졸리디논유도체및그의제조방법및항균제조성물
MXPA97000419A (en) 2-oxo and -tio-1, 2-dihydroquinolinyl-oxazolidine
EP3004056A1 (en) Novel pyrrole derivatives
KR20050099094A (ko) 새로운 세펨화합물과 그 제조방법 및 그를 함유하는항균제 조성물